|
CN112138038A
|
|
Tacrolimus pharmaceutical composition
|
|
CN112220880A
|
|
Pharmaceutical composition for treating atopic dermatitis
|
|
CN112156126A
|
|
Pharmaceutical composition of ezetimibe and licorice extract
|
|
CN112121142A
|
|
Pharmaceutical composition for preventing acute rejection of kidney transplantation and preparation method thereof
|
|
CN112121024A
|
|
Mecobalamin orally disintegrating tablet and preparation process thereof
|
|
CN112168827A
|
|
A pharmaceutical composition for treating psoriasis and preparation method thereof
|
|
CN111893154A
|
|
Method for producing sisomicin
|
|
CN111893153A
|
|
Method for extracting ademetionine fermentation liquor by breaking cell wall
|
|
CN111876366A
|
|
Fermentation method of micafungin sodium intermediate FR901379
|
|
CN111909244A
|
|
Preparation method of high-purity micafungin precursor FR901379
|
|
CN111909176A
|
|
Method for recovering ascomycin and tacrolimus 8-propyl analogue from tacrolimus separation waste liquid
|
|
CN111848561A
|
|
Method for purifying mycophenolic acid
|
|
CN111876455A
|
|
Method for producing paromomycin sulfate
|
|
CN111743870A
|
|
Preparation method of mecobalamin dispersible tablets
|
|
CN111388586A
|
|
Pharmaceutical compositions and formulations
|
|
CN111039963A
|
|
WXFL10203614 water-soluble analogue and synthetic method thereof
|
|
CN111380976A
|
|
Analysis method of doxercalciferol injection
|
|
CN111060628A
|
|
Method for detecting tacrolimus residual solvent
|
|
CN111000930A
|
|
Spray for treating external genitalia inflammation and preparation method thereof
|
|
CN111044635A
|
|
Method for analyzing content of mecobalamin particles
|
